Ruxolitinib coronavirus clinical trial : Incyte revealed that it is working with the US Food and Drug Administration (FDA) to launch the phase 3 RUXCOVID clinical trial to assess the…
Japan-based Fujifilm has started clinical trials to test the efficacy of Avigan, an anti-flu drug to treat coronavirus patients. Trials done in China suggested that Avigan might play a key…
Promega Corporation said that its GoTaq Probe 1-Step RT-qPCR System is now available in Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. Available through the CDC’s…
Johnson & Johnson said that it has selected a lead coronavirus vaccine candidate from constructs it has been working on since the start of this year, which it aims to…
The UK’s Medical Research Council has granted £5 million collectively to the University of Liverpool, the Imperial College London, and the University of Edinburgh to handle the coronavirus outbreak from…
Abbott ID NOW COVID-19 test : Medical device company Abbott has been granted Emergency Use Authorization (EUA) for its five-minute novel coronavirus diagnostic test from the US Food and Drug…
Promega master mix approved for use in CDC’s COVID-19 diagnostic panel
Promega Corporation said that its GoTaq Probe 1-Step RT-qPCR System is now available in Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use. Available through…
Abbott ID NOW COVID-19 test gets FDA nod to detect coronavirus in 5 mins
Abbott ID NOW COVID-19 test : Medical device company Abbott has been granted Emergency Use Authorization (EUA) for its five-minute novel coronavirus diagnostic test from the US Food…
behold.ai red dot algorithm identifies chest x-rays of coronavirus patients as abnormal
behold.ai claimed that its artificial intelligence-based red dot algorithm has been shown to have quickly identified chest X-rays from COVID-19 patients as ‘abnormal’. The UK-based healthtech company expects…
BreathTest-1000 coronavirus screening instrument developed by Astrotech
BreathTest-1000 coronavirus screening instrument : Astrotech said that it is developing the BreathTest-1000 screening instrument for coronavirus (COVID-19) and the associated pneumonia, and also other lung diseases. The…
Johnson & Johnson coronavirus vaccine targeted to be launched in early 2021
Johnson & Johnson said that it has selected a lead coronavirus vaccine candidate from constructs…
Lab established in Liverpool to study how novel coronavirus affects people
The UK’s Medical Research Council has granted £5 million collectively to the University of Liverpool,…
BioDuro launches AI-driven COVID-19 nanobody therapeutic program
BioDuro said that it has launched a COVID-19 nanobody therapeutic program by leveraging its biologics…
Polarisqb, Fujitsu join forces to create dengue drug discovery platform
Polarisqb has joined forces with Fujitsu to create a Dengue drug discovery platform that brings…
Japanese group AGC offers €240m bid for Italian biotech company Molmed
Japanese conglomerate AGC has offered a takeover bid of €240 million to acquire 100% of…
COVID-19 treatment : Cyclica, Institute of Materia Medica partner on drug repurposing for coronavirus
COVID-19 treatment : The Institute of Materia Medica, Chinese Academy of Medical Sciences has entered…
Gilead Sciences to acquire immuno-oncology company Forty Seven for $4.9bn
Gilead Sciences acquisition of Forty Seven : US biotech company Gilead Sciences has signed an…
Latest Pharma News
-
Incyte to launch ruxolitinib coronavirus clinical trial in US
-
Japan’s Fujifilm to test anti-flu drug Avigan to treat coronavirus
-
Promega master mix approved for use in CDC’s COVID-19 diagnostic panel
-
Johnson & Johnson coronavirus vaccine targeted to be launched in early 2021
-
Lab established in Liverpool to study how novel coronavirus affects people
-
Abbott ID NOW COVID-19 test gets FDA nod to detect coronavirus in 5 mins
-
behold.ai red dot algorithm identifies chest x-rays of coronavirus patients as abnormal
-
BioDuro launches AI-driven COVID-19 nanobody therapeutic program
-
RECOVERY coronavirus trial : First patients enrolled in COVID-19 clinical trial by University of Oxford
-
BreathTest-1000 coronavirus screening instrument developed by Astrotech
